{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T19:40:08Z","timestamp":1756323608074,"version":"3.44.0"},"reference-count":8,"publisher":"BMJ","issue":"6","license":[{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"unspecified","delay-in-days":10,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2025,4,26]]},"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:p>We describe a simple technique for removing fluocinolone acetonide (FAc) implant using 25 G instrumentation in an eye with uncontrolled glaucoma. The technique involved freeing the implant from the pars plana, lifting it from the posterior pole with 25G+Grieshaber Maxgrip forceps and transferring it to another forceps. The implant was then realigned coaxially and successfully removed through a 25G cannula without getting it dislodged. Fluocinolone implant could be safely removed through 25 G cannula in toto, and removal resulted in good control of intraocular pressure at 3-month and 9-month follow-up. This innovative bimanual handshake technique to transfer and realign the implant coaxially is a quicker and safer way to remove FAc implant, which avoids removing the cannula and thereby retains all advantages of 25G cannula, including better sclerotomy closure.<\/jats:p>","DOI":"10.1136\/bcr-2024-264235","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T04:30:29Z","timestamp":1749702629000},"page":"e264235","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Handshake technique for removal of fluocinolone acetonide implant from the vitreous cavity"],"prefix":"10.1136","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3799-6377","authenticated-orcid":false,"given":"Raja Rami","family":"Reddy","sequence":"first","affiliation":[{"name":"Retina, Ophthalmology, Neoretina Eyecare Institute, Hyderabad, Telangana, India"},{"name":"India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanita","family":"Pathak Ray","sequence":"additional","affiliation":[{"name":"Glaucoma, Centre for Sight, Hyderabad, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deependra Vikram","family":"Singh","sequence":"additional","affiliation":[{"name":"Retina Services, Eye-Q Super-Speciality Eye Hospitals, Gurugram, HR, India"},{"name":"R P Center for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, Delhi, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,6,12]]},"reference":[{"key":"2025082712081386000_18.6.e264235.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2016.05.025"},{"key":"2025082712081386000_18.6.e264235.2","unstructured":"Alimera Sciences Limited . ILUVIEN (fluocinolone acetonide intravitreal implant) 0.19 mg for intravitreal injection: US prescribing information. 2014. Available: https:\/\/iluvien.com\/wp-content\/uploads\/2024\/01\/Prescribing-Information.pdf"},{"key":"2025082712081386000_18.6.e264235.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2012.04.030"},{"key":"2025082712081386000_18.6.e264235.4","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1038\/eye.2017.125","article-title":"Real-world experience with 0.2\u2009\u03bcg\/day fluocinolone acetonide intravitreal implant (ILUVIEN) in the United Kingdom","volume":"31","author":"Bailey","year":"2017","journal-title":"Eye (Lond)"},{"key":"2025082712081386000_18.6.e264235.5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s40123-018-0155-5","article-title":"The USER Study: A Chart Review of Patients Receiving a 0.2 \u00b5g\/day Fluocinolone Acetonide Implant for Diabetic Macular Edema","volume":"8","author":"Eaton","year":"2019","journal-title":"Ophthalmol Ther"},{"key":"2025082712081386000_18.6.e264235.6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/ICB.0000000000001116","article-title":"SMALL-GAUGE TECHNIQUES FOR REMOVING A FLUOCINOLONE ACETONIDE IMPLANT","volume":"17","author":"Knight","year":"2023","journal-title":"Retin Cases Brief Rep"},{"key":"2025082712081386000_18.6.e264235.7","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1177\/24741264231200730","article-title":"Fluocinolone Acetonide Implant Removal From the Vitreous Cavity","volume":"7","author":"Valikodath","year":"2023","journal-title":"J Vitreoretin Dis"},{"key":"2025082712081386000_18.6.e264235.8","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jfo.2018.08.001","article-title":"The outcomes of bimanual posterior segment intraocular foreign body removal with vitrectomy and description of two different handshake techniques: A single surgeon case series","volume":"42","author":"Ozkaya","year":"2019","journal-title":"J Fr Ophtalmol"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2024-264235","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T19:08:19Z","timestamp":1756321699000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2024-264235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":8,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6,12]]},"published-print":{"date-parts":[[2025,6]]}},"alternative-id":["10.1136\/bcr-2024-264235"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2024-264235","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2025,6]]}}}